Skip to main content

Closed

ARVN: Arvinas, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+235.5% / yr

Operating margin-279.3%

ROIC-46.8%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage0.0×

Current ratio5.44×

Arvinas, Inc.

ARVNNASDAQ Global Select·USD·Closed

Arvinas, Inc.

ARVNNASDAQ·USD·Closed

$8.03

−3.25%

$8.03

−$0.27 (3.25%)

52W Range

23thpctl

Volume

0.79×avg

Mkt Cap

518.11MUSD

P/E

-2.5TTM

Div Yield

–ann

52W Range

23thpctl

Volume

0.79×avg

Market Cap

518.11MUSD

P/E Ratio

-2.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings